|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 411.25 INR | +0.72% |
|
-3.67% | -0.10% |
| 05-18 | Aarti Drugs Limited, Q4 2026 Earnings Call, May 18, 2026 | |
| 05-15 | Aarti Drugs Limited Announces Reconstitution of Risk Committee, Effective May 15, 2026 | CI |
| Market Cap | 37.69B 394M 346M 323M 296M 555M 568M 3.83B 1.5B 18.65B 1.48B 1.45B 64.48B | P/E 2026 |
15x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 37.69B 394M 346M 323M 296M 555M 568M 3.83B 1.5B 18.65B 1.48B 1.45B 64.48B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.32x |
| Free-Float |
39.83% | Yield 2026 * |
0.97% | Yield 2027 * | 1.19% |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | +0.72% | ||
| 1 week | -3.67% | ||
| Current month | +8.83% | ||
| 1 month | +10.34% | ||
| 3 months | +8.38% | ||
| 6 months | +6.90% | ||
| Current year | -0.10% |
| 1 week | 401 |  | 416.6 |
| 1 month | 369 | | 435.25 |
| Current year | 318.95 | | 435.25 |
| 1 year | 318.95 | | 549.3 |
| 3 years | 312 | | 635 |
| 5 years | 312 | | 687.8 |
| 10 years | 105.25 | | 1,026.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 79 | - | |
| Chief Executive Officer | 78 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 79 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.72% | -3.67% | - | - | 389M | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,089B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 643B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -1.69% | +8.81% | +39.38% | +34.26% | 359B | |
| -0.51% | +3.51% | +36.97% | +43.76% | 303B | |
| +1.50% | +3.40% | +17.71% | +18.77% | 267B | |
| +0.79% | +5.81% | -2.55% | -36.02% | 226B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 212B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 167B | |
| Average | -0.30% | +4.77% | +32.18% | +54.23% | 414.57B | |
| Weighted average by Cap. | -0.51% | +4.90% | +41.99% | +79.01% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 272M 239M 223M 205M 383M 393M 2.65B 1.04B 12.9B 1.02B 1B 44.59B | 28.65B 299M 263M 245M 225M 421M 432M 2.91B 1.14B 14.18B 1.12B 1.1B 49.01B |
| Net income | 1.82B 19.02M 16.71M 15.6M 14.32M 26.8M 27.46M 185M 72.35M 902M 71.42M 69.87M 3.12B | 2.05B 21.37M 18.78M 17.53M 16.09M 30.11M 30.86M 208M 81.29M 1.01B 80.24M 78.5M 3.5B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | ₹411.25 | +0.72% | 128,947 |
| 26-07-28 | ₹408.30 | -0.64% | 71,277 |
| 26-07-27 | ₹410.95 | +1.59% | 83,432 |
| 26-07-24 | ₹404.50 | -1.34% | 82,935 |
| 26-07-23 | ₹410.00 | -0.49% | 78,060 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 524348 Stock
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
